Sort
82,697 grants matching “vaccine development”
Advance Veterinary Services
$2,142,856Slobodan Paessler · University Of Texas Med Br Galveston · UC7 · FY2009 · AI
NIAID Microbiome Program
$2,142,762Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIC · FY2018 · AI
Development of antibody engineering-based cancer therapies
$2,142,050Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases
$2,141,672Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
PDT - Mechanisms and Strategies for Optimization
$2,141,103Barbara W. Henderson · Roswell Park Cancer Institute Corp · P01 · FY2011 · CA
SPORE for Translational Approaches to Brain Cancer
$2,140,963Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2025 · CA
Center of Biomedical Research Excellence in Pathogen Host Interactions
$2,140,849Bindu Nanduri · Mississippi State University · P20 · FY2022 · GM
Project Coordination and Product Development
$2,140,692Emory University · U19 · FY2004 · AI
BRAIN TUMOR SPORE GRANT
$2,140,227Mitchel S. Berger · University Of California, San Francisco · P50 · FY2011 · CA
CLINICAL AND LABORATORY STUDIES OF MALIGNANT LYMPHOMAS
$2,139,983Stanford University · P01 · FY2003 · CA
Rhinovirus Infections and Childhood Asthma
$2,139,538Robert F Lemanske · University Of Wisconsin-Madison · P01 · FY2008 · HL
Pathogenesis of E. coli and Shigella infections in human enteroid models
$2,139,153James B Kaper · University Of Maryland Baltimore · P01 · FY2023 · AI
Noroviruses and Epidemic Gastroenteritis
$2,139,101Kim Y. Green · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Mayo Clinic Ovarian Cancer SPORE
$2,139,000Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2019 · CA
SPORE in Myeloid Malignancies
$2,138,999Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2021 · CA
SPORE in Myeloid Malignancies
$2,138,999Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2019 · CA
The Gonorrhea Vaccine Cooperative Research Center
$2,138,476Ann E. Jerse · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2023 · AI
Immunogen Design for Induction of HIV distal gp41 broadly neutralizing antibodies
$2,138,470S Munir Alam · Duke University · P01 · FY2020 · AI
Rhythms of Resistance: Unraveling the impact of natural circadian variation on immunity
$2,138,125Ben N. Mansfeld · Washington University · R35 · FY2025 · GM
NIAID Preclinical Development Support
$2,137,425Jon Carl Mirsalis · Advanced Bioscience Laboratories, Inc. · N01 · FY2013 · AI
University of North Carolina AIDS Clinical Trials Unit (UNC ACTU)
$2,136,814Joseph J. Eron · Univ Of North Carolina Chapel Hill · U01 · FY2007 · AI
Noncoding RNA structures and interactions in cellular stress responses and immunity
$2,136,574Jinwei Zhang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Cellular and Molecular Defects in Human B Cell Development
$2,136,538Charlotte Cunningham-Rundles · Icahn School Of Medicine At Mount Sinai · P01 · FY2019 · AI
LIVE ATTENUATED MULTIPLY DELETED HIV1 VACCINE FOR AIDS
$2,135,845Harvard University (Medical School) · P01 · FY2002 · AI
Intracellular pathogens and innate immunity
$2,135,624Daniel A Portnoy · University Of California Berkeley · P01 · FY2016 · AI